Reviva Pharmaceuticals Holdings Inc 뉴스 - RVPH | 주식 나스닥 | ADVFN

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Reviva Pharmaceuticals Holdings Inc (RVPH)
Reviva Pharmaceuticals Holdings Inc (RVPH) 뉴스

Reviva Pharmaceuticals Holdings Inc (RVPH)

1.43

0.09

(6.72%)

마감 28 2월 6:00AM

1.41

-0.02

( -1.40% )

시간외 단일가: 9:31PM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K/A - Current report: [Amend]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form EFFECT - Notice of Effectiveness

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Eagle1

Eagle1 4 주 전

RVPH Nice chart here glenn. Thanks looking forward to a nice move here soon.

RVPH.....................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 2 월 전

RVPH.....................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

Eagle1

Eagle1 2 월 전

RVPH 1.8797 0.0797 (4.43%) 12-30-24

glenn1919

glenn1919 2 월 전

RVPH...........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

Eagle1

Eagle1 2 월 전

RVPH $1.63 0.29 (+21.64%) Liking this one, can't believe you didn't alert me before...

shame on you, LOL jk buddy, lets see this to $3.00++ soon looks very solid.

govprs

govprs 2 월 전

Great place to add. Gltu

Eagle1

Eagle1 2 월 전

glenn1919

glenn1919 2 월 전

RVPH..................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

McMagyar

McMagyar 2 월 전

Pulling defeat from absolute victory.
Absolute Trainwreck of a management team..
Sad to watch..
If you had a competent ceo .. this would have been a billion dollar market cap..
No One has confidence in the ceo other than to bank his paycheck..
so many people could have been helped with this drug .. by the time they get approval the patent will be gone.. maybe they will crystallize the formula and we can start all over again..
Just tough to watch.. usually the system screws these small biopharms, but Reviva over decades seems to have a talent( not unique) of finding ways do it to themselves

glenn1919

glenn1919 3 월 전

RVPH........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 월 전

RVPH.............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 월 전

RVPH...........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 월 전

RVPH...............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

Paullee

Paullee 3 월 전

crazy going on today

govprs

govprs 3 월 전

Might be imminent big vol today

stockweiser

stockweiser 3 월 전

OLE data in December.

Termite7

Termite7 3 월 전

Any news before year end? .......Thanks!!!!

glenn1919

glenn1919 4 월 전

RVPH.......................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

Termite7

Termite7 5 월 전

ETA on approval? .......Thanks!!!

Imokhopeur

Imokhopeur 6 월 전

No doubt Termite

Termite7

Termite7 6 월 전

This could get to $8-or-$12 depending upon drug-approval.......

......and their pipeline is HUGE!!!!

glenn1919

glenn1919 6 월 전

RVPH.................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783

Imokhopeur

Imokhopeur 6 월 전

It will soon make up its mind to pass 1.00 and quickly move up!!!

Triple nickle

Triple nickle 6 월 전

Imokhopeur

Imokhopeur 6 월 전

Monksdream

Monksdream 6 월 전

RVPH new 52=low

Monksdream

Monksdream 7 월 전

RVPH new 52 week low

Monroe1

Monroe1 8 월 전

OPennyS

OPennyS 8 월 전

Because we have a long wait.

This data is crucial for their planned New Drug Application (NDA) submission to the FDA, expected in the fourth quarter of 2025.

Paullee

Paullee 8 월 전

https://synapse.patsnap.com/article/reviva-updates-enrollment-for-brilaroxazine-schizophrenia-study

Monroe1

Monroe1 8 월 전

Why is this continuing to tank? Trial data not good?

McMagyar

McMagyar 11 월 전

Well it’s below 4 not 3..
And I am praying they just sell but..
Arrogance is strong..
Also Nutriband is killing it..
Also anavex just announce the start of their schizophrenia trial..

Sell the co doc.. what lease can I say

Monksdream

Monksdream 11 월 전

McMagyar

McMagyar 1 년 전

We’re just gonna wake up to a $200 sold co..

govprs

govprs 1 년 전

Im back in now for the next flip opportunity

2H2

I closed out my shares end of day. Way outside daily bb, renter on pullback

govprs

govprs 1 년 전

I would fade this. I did to be honest got a nice profit today. I believe a buyout is possible here but they need to make progress p3 trial. I’m looking to re-enter 380 -405 range. Glta

2H2

KRTX bought by BMY

McMagyar

McMagyar 1 년 전

I thought this was anavex!!

Haha

Revival would make sense
They have poorly managed the finances and development of this great drug for decades
Let someone else bring it to market

McMagyar

McMagyar 1 년 전

That would be a disaster for humanity
Poison pill to discourage such activity is in place
There will be no buyout
There will be no marketing partnerships

We are going straight to govts to lower their healthcare costs

2H2

Potential buyout here soon imo

McMagyar

McMagyar 1 년 전

Another drug which Blarcamesine could act as empowering agent

McMagyar

McMagyar 1 년 전

Because it’s a lifelong drug..
It treats symptoms safely.. but
unfortunately deoant cure the imbalance
so .. once someone is on.. they will probably never stop ..

Phase 4 confirmatory / safety would make more sense ..after nda filed and drug aold

McMagyar

McMagyar 1 년 전

23.9 improvement.

No safety issues

Get the sick the drug

The fda process sucks

govprs

govprs 1 년 전

No they still have to complete another trial. It says so in the pr. If you missed the pump to 6ish then im sorry for you.

McMagyar

McMagyar 1 년 전

23.9 point improvement!
That is incredulous!

INCREDULOUS!

McMagyar

McMagyar 1 년 전

25 ? Haha..
NDA now
Use now..

govprs

govprs 1 년 전

Sure they will but no nda till q1 2025. Plus this is heavily shorted.

I could be wrong and if I am atleast I made a few bucks today gltu

McMagyar

McMagyar 1 년 전

Word is they will be filing nda and become the first choice for all mental suffering humans..
Cross prescriptions for dementia..etcal..
Buy back in at $30

govprs

govprs 1 년 전

Yep it was a big day with phase 3 success. Word is they will need to raise cash

I sold out with a profit and will look to get back in at some point

Reviva Pharmaceuticals

Societe Generale Effekten

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관